Rituximab
Concept
Vocabulary Service
Overview
subject area of
-
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Academic Article
-
A Canadian phase II study evaluating the efficacy of rituximab in the management of patients with relapsed/refractory thrombotic thrombocytopenic purpura Conference Paper
-
A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia Academic Article
-
A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab Academic Article
-
A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia Academic Article
-
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed ch Academic Article
-
An atypical case of bilateral posterior scleritis in a patient with chronic lymphocytic leukemia Academic Article
-
Anti-cytokine targeted therapies for ANCA-associated vasculitis Academic Article
-
Application of the systematic review and bibliometric network analysis (SeBriNA) methodology contextualizes evidence. Part 2: rituximab for non-Hodgkin's lymphoma Academic Article
-
Autoimmune haemolytic anaemia associated with epstein barr virus infection as a severe late complication after kidney transplantation and successful treatment with rituximab: case report Academic Article
-
Autologous Stem Cell Transplantation in Follicular Lymphoma: a Systematic Review and Meta-analysis Academic Article
-
Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma Academic Article
-
Autologous and Allogeneic Stem-Cell Transplantation for Transformed Follicular Lymphoma: A Report of the Canadian Blood and Marrow Transplant Group Academic Article
-
Autologous transplantation improves survival rates for follicular lymphoma patients who relapse within two years of chemoimmunotherapy: a multi-center retrospective analysis of consecutively treated patients in the real world Academic Article
-
Bortezomib Added to R-CVP Is Safe and Effective for Previously Untreated Advanced-Stage Follicular Lymphoma: A Phase II Study by the National Cancer Institute of Canada Clinical Trials Group Academic Article
-
Childhood Immune Thrombocytopenia: A Changing Therapeutic Landscape Academic Article
-
Conference abstracts of a new oncology drug do not always lead to full publication: Proceed with caution Academic Article
-
Cost-effectiveness analysis of rituximab with methotrexate, cytarabine and thiotepa for the treatment of patients with primary central nervous system lymphoma Academic Article
-
Current Options for the Treatment of Idiopathic Thrombocytopenic Purpura Academic Article
-
Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient Academic Article
-
Eculizumab in a Patient with Dense-Deposit Disease Academic Article
-
Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12* Academic Article
-
Evaluation of Subcutaneous Rituximab Administration on Canadian Systemic Therapy Suites Academic Article
-
Favorable Outcomes from Allogeneic and Autologous Stem Cell Transplantation for Patients with Transformed Nonfollicular Indolent Lymphoma Academic Article
-
Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma Conference Paper
-
First-Line Therapy, Autologous Stem-Cell Transplantation, and Post-Transplantation Maintenance in the Management of Newly Diagnosed Mantle Cell Lymphoma Academic Article
-
Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura Academic Article
-
Hepatitis B, Rituximab, Screening, and Prophylaxis: Effectiveness and Cost Effectiveness Academic Article
-
ISTH guidelines for treatment of thrombotic thrombocytopenic purpura Academic Article
-
Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study Academic Article
-
Immunotherapies in Dermatologic Disorders Academic Article
-
Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin's lymphoma Academic Article
-
Improved survival in overweight and obese patients with aggressive B-cell lymphoma treated with rituximab-containing chemotherapy for curative intent Academic Article
-
In patients with rheumatoid arthritis, bDMARD therapy was not associated with malignant neoplasms Academic Article
-
Life-threatening hemolytic anemia due to an autoanti-Pr cold agglutinin: evidence that glycophorin A antibodies may induce lipid bilayer exposure and cation permeability independent of agglutination Academic Article
-
Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia Academic Article
-
Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia Academic Article
-
Mixed Variant Multicentric Castleman Disease Treated With Rituximab: Case Report Academic Article
-
Monoclonal gammopathy and glomerulopathy associated with chronic lymphocytic leukemia Academic Article
-
New treatments for idiopathic thrombocytopenic purpura: rethinking old hypotheses Academic Article
-
Outcomes for transformed follicular lymphoma in the rituximab era: the Royal Marsden experience 2003–2013 Academic Article
-
Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704 Academic Article
-
Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma Academic Article
-
Physician decision making in selection of second-line treatments in immune thrombocytopenia in children Academic Article
-
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis Academic Article
-
Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT Academic Article
-
Positioning new treatments in the management of immune thrombocytopenia Academic Article
-
Prevalence and significance of large granular lymphocytes in patients with immune thrombocytopenia Academic Article
-
Pure red cell aplasia complicating B cell small lymphocytic lymphoma: a case report Academic Article
-
R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial Academic Article
-
Regulatory B10 Cells Increase after Rituximab Therapy but Not after Conventional Immunosuppression in Patients with Pemphigus Academic Article
-
Risk infection to spare bleeding? The quandary of splenectomy for immune thrombocytopenia Academic Article
-
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis Academic Article
-
Rituximab for Sight-Threatening Lupus-Related Retinal Vasculitis Academic Article
-
Rituximab in Lymphoma and Chronic Lymphocytic Leukaemia: A Practice Guideline Academic Article
-
Rituximab in lymphoma: A systematic review and consensus practice guideline from Cancer Care Ontario Academic Article
-
Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect Academic Article
-
Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura Academic Article
-
Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis Academic Article
-
Rituximab utilization for approved and off‐label nononcology indications and patients’ experiences with the Patient Alert Card Academic Article
-
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis Academic Article
-
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial Academic Article
-
Safety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell Lymphoma Academic Article
-
Second‐line treatments in children with immune thrombocytopenia: Effect on platelet count and patient‐centered outcomes Academic Article
-
Splenectomy for immune thrombocytopenia: down but not out Academic Article
-
Successful treatment of multiply relapsed lymphoma with rituximab as a single agent Academic Article
-
Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura Academic Article
-
Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin Academic Article
-
Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial Academic Article
-
The Completeness of Reporting (CORE) index identifies important deficiencies in observational study conference abstracts Academic Article
-
The effect of rituximab on anti-platelet autoantibody levels in patients with immune thrombocytopenia Academic Article
-
The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases Academic Article
-
The effect of rituximab on vaccine responses in patients with immune thrombocytopenia Academic Article
-
The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura Academic Article
-
Thrombotic thrombocytopenic purpura in pediatric patients. Academic Article
-
Thrombotic thrombocytopenic purpura: 2008 Update Academic Article
-
Treatment Strategies in Elderly Patients with Aggressive Histology Lymphoma Academic Article
-
Treatment and its side effects in ANCA-associated vasculitides – Study based on POLVAS registry data Academic Article
-
Tubular Lesions Predict Renal Outcome in Antineutrophil Cytoplasmic Antibody–Associated Glomerulonephritis after Rituximab Therapy Academic Article
-
Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma Academic Article
-
Updates in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis: At a crossroad Academic Article
-
Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis Academic Article
-
Use of anti-CD20 antibody in the treatment of post-transplant glomerulonephritis Academic Article